CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi
Intest Res. 2021;19(3):301-312.   Published online August 20, 2020
DOI: https://doi.org/10.5217/ir.2020.00013

Excel Download

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Intestinal Research. 2021;19(3):301-312   Crossref logo
Link1 Link2 Link3

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
Intestinal Research. 2021;19(4):408-418   Crossref logo
Link1 Link2 Link3

Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
Intestinal Research. 2021;19(4):419-429   Crossref logo
Link1 Link2 Link3

Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study
Clinical Rheumatology. 2016;36(2):451-455   Crossref logo
Link1 Link2 Link3

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study
Pituitary. 2019;22(5):542-551   Crossref logo
Link1 Link2 Link3

OC.02.8 A PROSPECTIVE “REAL LIFE” STUDY ON ADALIMUMAB EFFICACY IN STEROID-DEPENDENT CROHN'S DISEASE PATIENTS: RESULTS FROM A LONG TERM FOLLOW-UP
Digestive and Liver Disease. 2016;48:e78   Crossref logo
Link1 Link2

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease
Internal and Emergency Medicine. 2018;14(5):719-722   Crossref logo
Link1 Link2 Link3

Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients
Modern Rheumatology. 2017;28(1):30-38   Crossref logo
Link1 Link2

Adalimumab long-term safety/efficacy results for pediatric patients with chronic plaque psoriasis from a phase 3, randomized study
Journal of the American Academy of Dermatology. 2016;74(5):AB209   Crossref logo
Link1 Link2

Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice
Digestive Diseases. 2018;37(1):11-20   Crossref logo
Link1 Link2